1,222
Views
28
CrossRef citations to date
0
Altmetric
Reviews

Curcuminoids from Curcuma Longa: New adjuvants for the treatment of crohn's disease and ulcerative colitis?

, , , & ORCID Icon

References

  • Akobeng, A. K., M. Elawad, and M. Gordon. 2016. Glutamine for induction of remission in Crohn's disease. Cochrane Database System Reviews CD007348. doi:10.1002/14651858.CD007348.pub2. Review.
  • Algieri, F., A. Rodriguez-Nogales, M. E. Rodriguez-Cabezas, S. Risco, M. A. Ocete, and J. Galvez. 2015. Botanical drugs as an emerging strategy in inflammatory bowel disease: A review. Mediators of Inflammation 2015:179616. doi:10.1155/2015/179616.
  • Ameruoso, A., R. Palomba, A. L. Palange, A. Cervadoro, A. Lee, D. Di Mascolo, and P. Decuzzi. 2017. Ameliorating amyloid-β fibrils triggered inflammation via curcumin-loaded polymeric nanoconstructs. Frontiers in Immunology 8:1411. doi:10.3389/fimmu.2017.01411.
  • Azevedo, M. F. C. C. A. S., L. R. Milani, J. Oba, and A. O. M. C. Damião. 2014. Doença inflamatória intestinal. Revista Brasileira De Medicina 71:46–58.
  • Baliga, M. S., N. Joseph, M. V. Venkataranganna, A. Saxena, V. Ponemone, and R. Fayad. 2012. Curcumin, an active component of turmeric in the prevention and treatment of ulcerative colitis: preclinical and clinical observations. Food Function 3:1109–17. doi:10.1039/c2fo30097d.
  • Barbalho, S. M., R. A. Goulart, and R. G. Gasparini. 2017. Associations between inflammatory bowel diseases and vitamin D. Critical Reviews in Food Science and Nutrition. Dec 13:1–10. doi: 10.1080/10408398.2017.1406333.
  • Bastaki, S. M. A., M. M. Al Ahmed, A. Al Zaabi, N. Amir, and E. Adeghate. 2016. Effect of turmeric on colon histology, body weight, ulcer, IL-23, MPO and glutathione in acetic-acid-induced inflammatory bowel disease in rats. BMC Complementary and Alternative Medicine 16:72. doi:10.1186/s12906-016-1057-5.
  • Chen, Q., X. Si, L. Ma, P. Ma, M. Hou, S. Bai, X. Wu, Y. Wan, B. Xiao, and D. Merlin. 2017. Oral delivery of curcumin via porous polymeric nanoparticles for effective ulcerative colitis therapy. Journal of Materials Chemistry B Materials For Biology and Medicine. 5:5881–91. doi:10.1039/C7TB00328E.
  • Chin, K. Y. 2016. The spice for joint inflammation: anti-inflammatory role of curcumin in treating osteoarthritis. Drug Design, Development and Therapy 10:3029–42. doi:10.2147/DDDT.S117432.
  • Fontani, F., T. Marcucci, L. Picariello, F. Tonelli, M. T. Vincenzini, and T. Iantomasi. 2014. Redox regulation of MMP-3/TIMP-1 ratio in intestinal myofibroblasts: effect of N-acetylcysteine and curcumin. Experimental Cell Research 15;323(1):77–86. doi:10.1016/j.yexcr.2014.02.019.
  • Gadaleta, R. M., O. Garcia-Irigoyen, and A. Moschetta. 2017. Exploration of inflammatory bowel disease in mice: Chemically induced murine models of inflammatory bowel disease (IBD). Current Protocols in Mouse Biology 7:13–28. doi:10.1002/cpmo.20.
  • Ganji-Arjenaki, M., H. Nasri, and M. Rafieian-Kopaei. 2017. Nephrolithiasis as a common urinary system manifestation of inflammatory bowel diseases; a clinical review and meta-analysis. Journal of Nephropathol. 6:264–69. doi:10.15171/jnp.2017.42.
  • Gopi, S., A. Amalraj, S. Jude, K. Varma, T. R. Sreeraj, J. T. Haponiuk, and S. Thomas. 2017. Preparation, characterization and anti-colitis activity of curcumin-asafoetida complex encapsulated in turmeric nanofiber. Materials Science and Engineering C Materials Biology Applied. 81:20–31. doi:10.1016/j.msec.2017.07.037.
  • Hanai, H., and K. Sugimoto. 2009. Curcumin has bright prospects for the treatment of inflammatory bowel disease. Current Pharmaceutical 15:2087–94. doi:10.2174/138161209788489177.
  • Hart, A. L., H. O. Al-Hassi, R. J. Rigby, S. J. Bell, A. V. Emmanuel, S. C. Knight, M. A. Kamm, and A. J. Stagg. 2005. Characteristics of intestinal dendritic cells in inflammatory bowel diseases. Gastroenterology 129:50–65. doi:10.1053/j.gastro.2005.05.013.
  • Hatcher, H., R. Planalp, J. Cho, F. M. Torti, and S. V. Torti. 2008. Curcumin: From ancient medicine to current clinical trials. Cellular and Molecular Life Sciences 65:1631–52. doi:10.1007/s00018-008-7452-4.
  • Hemachandra, R. P., M. Manczak, X. Yin, M. C. Grady, A. Mitchell, S. Tonk, C. S. Kuruva, J. S. Bhatti, R. Kandimalla, M. Vijayan, et al. 2018. Protective Effects of Indian Spice Curcumin Against Amyloid-β in Alzheimer's Disease. Journal of Alzheimer's Disease 2018;61(3):843–66. doi:10.3233/JAD-170512.
  • Hemperly, A., and N. Vande-Casteele. 2018. Clinical Pharmacokinetics and Pharmacodynamics of Infliximab in the Treatment of Inflammatory Bowel Disease. Clinical Pharmacokinectics 12. doi:10.1007/s40262-017-0627-0.
  • Henriksen, M., M. L. Høivik, L. P. Jelsness-Jørgensen, B. Moum, and IBSEN Study Group. 2017. Irritable bowel-like symptoms in ulcerative colitis are as common in patients in deep remission as with inflammation; results from a population-based study (the IBSEN study). Journal of Crohn's and Colitis. doi:10.1093/ecco-jcc/jjx152.
  • Hu, X., F. Huang, M. Szymusiak, Y. Liu, and Z. J. Wang. 2015. Curcumin attenuates opioid tolerance and dependence by inhibiting Ca2+/calmodulin-dependent protein kinase II α activity. Journal of Pharmacology and Experimental Therapeutics 352:420–28. doi:10.1124/jpet.114.219303.
  • Huang, G., L. Ye, G. Du, Y. Huang, Y. Wu, S. Ge, Z. Yang, and G. Zhu. 2017. Effects of curcumin plus Soy oligosaccharides on intestinal flora of rats with ulcerative colitis. Cellular and Molecular Biology (Noisy-le-grand) 63:20–25. doi:10.14715/cmb/2017.63.7.3.
  • Ilhara, S., Y. Hirata, and K. Koike. 2017. TGF-β in inflammatory bowel disease: a key regulator of immune cells, epithelium, and the intestinal microbiota. Journal of Gastroenterol. 52:777–87. doi:10.1007/s00535-017-1350-1.
  • Kadri, C. J., J. A. Pereira, F. G. Campos, M. M. Ortega, C. B. Bragion, and C. A. Martinez. 2017. Anti-inflammatory effects of enemas containing an oily extract of curcumin in an experimental model of diversion colitis. Histology and Histopathology 32:161–69.
  • Kappelman, M. D., S. L. Rifas-Shiman, C. Q. Porter, D. A. Ollendorf, R. S. Sandler, J. A. Galanko, and J. A. Finkelstein. 2008. Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults. Gastroenterology 135:1907–13. doi:10.1053/j.gastro.2008.09.012.
  • Khan, I., S. E. Samson, and A. K. Grover. 2017. Antioxidant Supplements and Gastrointestinal Diseases: A Critical Appraisal. Medical Principles and Practice 26:201–17. doi:10.1159/000468988.
  • Kim, J. H., S. Jin, H. J. Kwon, and B. W. Kim. 2016. Curcumin Blocks Naproxen-Induced Gastric Antral Ulcerations through Inhibition of Lipid Peroxidation and Activation of Enzymatic Scavengers in Rats. Journal of Microbiology and Biotechnology 26:1392–97. doi:10.4014/jmb.1602.02028.
  • Kondamudi, P. K., H. Kovelamudi, P. G. Nayak, M. C. Rao, and R. R. Shenoy. 2015. Curcumin half analog modulates interleukin-6 and tumor necrosis factor-alpha in inflammatory bowel disease. Pharmacognosy Magazine 11:296–302. doi:10.4103/0973-1296.165991.
  • Kotze, P. G. K., I. C. Albuquerque, A. C. Moraes, A. Vieira, and F. Souza. 2009. Análise de custo-minimização entre o Infliximabe (IFX) e o Adalimumabe (ADA) no tratamento da doença de Crohn (DC). Revista Brasileira de Colo-proctologia 29:158–68. doi:10.1590/S0101-98802009000200002.
  • Kuo, P. C., C. J. Yang, Y. C. Lee, P. C. Chen, Y. C. Liu, and S. N. Wu. 2018. The comprehensive electrophysiological study of curcuminoids on delayed-rectifier K+ currents in insulin-secreting cells. European Journal of Pharmacology 819:233–41. doi:10.1016/j.ejphar.2017.12.004.
  • Lang, A., N. Salomon, J. C. Wu, U. Kopylov, A. Lahat, O. Har-Noy, J. Y. Ching, P. K. Cheong, B. Avidan, D. Gamus, et al. 2015. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial. Clinical Gastroenterology and Hepatology 13:1444–49. doi:10.1016/j.cgh.2015.02.019.
  • Lanis, J. M., D. J. Kao, E. E. Alexeev, and S. P. Colgan. 2017. Tissue metabolism and the inflammatory bowel diseases. Journal of Molecular Medicine 95:905–13. doi:10.1007/s00109-017-1544-2.
  • Li, C. P., J. H. Li, S. Y. He, O. Chen, and L. Shi. 2015. Effect of curcumin on p38MAPK expression in DSS-induced murine ulcerative colitis. Genetics and Molecular Research 14:3450–58. doi:10.4238/2015.April.15.8.
  • Liu, F., S. Gao, Y. Yang, X. Zhao, Y. Fan, W. Ma, D. Yang, A. Yang, and Y. Yu. 2018. Antitumor activity of curcumin by modulation of apoptosis and autophagy in human lung cancer A549 cells through inhibiting PI3K/Akt/mTOR pathway. Oncology Reports 39 (3):1523–31. doi:10.3892/or.2018.6188.
  • Liu, L., Y. L. Liu, G. X. Liu, X. Chen, K. Yang, Y. X. Yang, Q. Xie, H. K. Gan, X. L. Huang, and H. T. Gan. 2013. Curcumin ameliorates dextran sulfate sodium-induced experimental colitis by blocking STAT3 signaling pathway. International Immunopharmacology 17:314–20. doi:10.1016/j.intimp.2013.06.020.
  • Loganes, C., S. Lega, M. Bramuzzo, L. V. Brumatti, E. Piscianz, E. Valencic, A. Tommasini, and A. Marcuzzi. 2017. Curcumin anti-apoptotic action in a model of intestinal epithelial inflammatory damage. Nutrients 9:578. doi:10.3390/nu9060578.
  • McCann, M. J., S. Johnston, K. Reilly, X. Men, E. J. Burgess, N. B. Perry, and N. C. Roy. 2014. The effect of turmeric (Curcuma longa) extract on the functionality of the solute carrier protein 22 A4 (SLC22A4) and interleukin-10 (IL-10) variants associated with inflammatory bowel disease. Nutrients 6:4178–90. doi:10.3390/nu6104178.
  • Moghadam, A. R., D. Mohajeri, A. Namvaran-Abbas-Abad, H. Manafi, D. Shahi, and M. Mazani. 2013. Protective effect of turmeric extract on methotrexate-induced intestinal damage and oxidative stress. Chinese Journal of Natural Medicines 11(5):477–83. doi:10.1016/S1875-5364(13)60087-4.
  • Mouzaoui, S., I. Rahim, and B. Djerdiouri. 2012. Aminoguanidine and curcumin attenuated tumor necrosis factor (TNF)-α-induced oxidative stress, colitis and hepatotoxicity in mice. International Immunopharmacology 12:302–11. doi:10.1016/j.intimp.2011.10.010.
  • Rachmawati, H., A. T. Pradana, D. Safitri, and I. K. Adnyana. 2017. Multiple Functions of D-α-Tocopherol Polyethylene Glycol 1000 Succinate (TPGS) as CurcuminNanoparticle Stabilizer: In Vivo Kinetic Profile and Anti-Ulcerative Colitis Analysis in Animal Model. Pharmaceutics 9 (3):1–13. pii: E24. doi:10.3390/pharmaceutics9030024.
  • Rajasekaran, S. A. 2011. Therapeutic potential of curcumin in gastrointestinal diseases. World Journal of Gastrointestinal Pathophysiology 2:1–14 doi:10.4291/wjgp.v2.i1.1.
  • Sairenji, T., K. L. Collins, and D. V. Evans. 2017. An update on inflammatory bowel disease. Primary Care 44:673–92. doi:10.1016/j.pop.2017.07.010.
  • Santel, T., G. Pflug, N. Y. Hemdan, A. Schäfer, M. Hollenbach, M. Buchold, A. Hintersdorf, I. Lindner, A. Otto, M. Bigl, et al. 2008. Curcumin inhibits glyoxalase 1—A possible link to its anti-inflammatory and anti-tumor activity. PLoS ONE. 3 (10):1–13: e3508. doi:10.1371/journal.pone.0003508.
  • Sartor, R. B. 2006. Mechanisms of disease: Pathogenesis of Crohn's disease and ulcerative colitis. Nature Clinical Practice Gastroenterology & Hepatology 3:390–407 doi:10.1038/ncpgasthep0528.
  • Schaffer, M., P. M. Schaffer, J. Zidan, and G. Bar Sela. 2011. Curcuma as a functional food in the control of cancer and inflammation. Current Opinion in Clinical Nutrition & Metabolic Care 14:588–97. doi:10.1097/MCO.0b013e32834bfe94.
  • Seo, E. J., N. Fischer, and T. Efferth. 2017. Phytochemicals as inhibitors of NF-κB for treatment of Alzheimer's disease. Pharmacology Research. 129:262–73. doi:10.1016/j.phrs.2017.11.030.
  • Shalkami, A. S., M. Hassan, and A. G. Bakr. 2018. Anti-inflammatory, antioxidant and anti-apoptotic activity of diosmin in acetic acid-induced ulcerative colitis. Human & Experimental Toxicology 37:78–86. doi:10.1177/0960327117694075.
  • Singla, V., V. Pratap Mouli, S. K. Garg, T. Rai, B. N. Choudhury, P. Verma, R. Deb, V. Tiwari, S. Rohatgi, R. Dhingra, et al. 2014. Inductionwith NCB-02 (curcumin) enema for mild-to-moderate distal ulcerativecolitis – a randomized, placebo-controlled, pilotstudy. Journal of Crohn's and Colitis 8:208–14 doi:10.1016/j.crohns.2013.08.006.
  • Sueth-Santiago, V., G. P. Mendes-Silva, D. Decote-Ricardo, and M. E. F. Lima. 2015. Curcumina, o pó dourado do açafrão-da-terra: instrospecções e atividades biológicas. Química Nova 38:538–52.
  • Suskind, D. L., G. Wahbeh, T. Burpee, M. Cohen, D. Christie, and W. Weber. 2013. Tolerability of curcumin in pediatric inflammatory bowel disease: a forced-dose titration study. Journal of Pediatric Gastroenterology and Nutrition 56:277–79. doi:10.1097/MPG.0b013e318276977d.
  • Topcu-Tarladacalisir, Y., M. Akpolat, Y. H. Uz, G. Kizilay, M. Sapmaz-Metin, A. Cerkezkayabekir, and I. K. Omurlu. 2013. Effects of curcumin on apoptosis and oxidoinflammatory regulation in a rat model of acetic acid–induced colitis: The roles of c-Jun N-terminal kinase and p38 mitogen-activated protein kinase. Journal of Medicinal Food 16:296–305. doi:10.1089/jmf.2012.2550.
  • Wang, Y., X. Gao, A. Ghozlane, H. Hu, X. Li, Y. Xiao, D. Li, G. Yu, and T. Zhang. 2017. Characteristics of fecal microbiota in pediatric Crohn's disease and their dynamic changes during infliximab therapy. Journal of Crohn's and Colitis 2 (3):337–46. doi:10.1093/ecco-jcc/jjx153.
  • Xiao, B., Z. Zhang, E. Viennois, Y. Kang, M. Zhang, M. K. Han, J. Chen, and D. Merlin. 2016. Combination therapy for ulcerative colitis: Orally targeted nanoparticles prevent mucosal damage and relieve inflammation. Theranostics 6:2250–66. doi:10.7150/thno.15710.
  • Yang, M., J. Wang, C. Yang, H. Han, W. Rong, and G. Zhang. 2017. Oral administration of curcumin attenuates visceral hyperalgesia through inhibiting phosphorylation of TRPV1 in rat model of ulcerative colitis. Molecular Pain. doi:10.1177/1744806917726416.
  • Yildirim, H., F. B. Sunay, S. Sinan, and F. Köçkar. 2016. In vivo effects of curcumin on the paraoxonase, carbonic anhydrase, glucose-6-phosphate dehydrogenase and β-glucosidase enzyme activities in dextran sulphate sodium-induced ulcerative colitis mice. Journal of Enzyme Inhibition and Medicinal Chemistry 31 (6):1583–90. doi:10.3109/14756366.2016.1158173.
  • Yu, Y. R., and J. R. Rodriguez. 2017. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes. Seminars in Pediatric Surgery. 26:349–55. doi:10.1053/j.sempedsurg.2017.10.003.
  • Zhao, H. M., R. Xu, X. Y. Huang, S. M. Cheng, M. F. Huang, H. Y. Yue, X. Wang, Y. Zou, A. P. Lu, and D. Y. Liu. 2016. Curcumin improves regulatory T cells in gut-associated lymphoid tissue of colitis mice. World Journal of Gastroenterology 22:5374–83. doi:10.3748/wjg.v22.i23.5374.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.